Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak

[1]  Pardis C Sabeti,et al.  Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time , 2020, Nature Communications.

[2]  Mosoka P. Fallah,et al.  Lassa virus circulating in Liberia: a retrospective genomic characterisation. , 2019, The Lancet. Infectious diseases.

[3]  R. Hatchett,et al.  Developing vaccines against epidemic-prone emerging infectious diseases , 2019, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[4]  S. Günther,et al.  Lassa Virus in Pygmy Mice, Benin, 2016–2017 , 2019, Emerging infectious diseases.

[5]  P. Lemey,et al.  Phylogeography of Lassa Virus in Nigeria , 2019, Journal of Virology.

[6]  Pardis C Sabeti,et al.  Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria , 2019, Emerging infectious diseases.

[7]  S. Günther,et al.  Ribavirin for the Treatment of Lassa Fever: A Systematic Review and Meta-Analysis. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  E. Musa,et al.  Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018 , 2019, Emerging infectious diseases.

[9]  D. Emperador,et al.  Diagnostic applications for Lassa fever in limited-resource settings , 2019, BMJ Global Health.

[10]  Laura Mazzola,et al.  Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings , 2019, BMJ Global Health.

[11]  M. A. Suchard,et al.  Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak , 2019, Science.

[12]  Kevin F. Jones,et al.  A potent Lassa virus antiviral targets an arenavirus virulence determinant , 2018, PLoS pathogens.

[13]  Pardis C Sabeti,et al.  Genomic analysis of Lassa virus from the 2018 surge in Nigeria , 2018, The New England Journal of Medicine.

[14]  Catherine A. Freije,et al.  Genomic analysis of Lassa virus from the 2018 surge in Nigeria , 2018, The New England journal of medicine.

[15]  Pardis C Sabeti,et al.  Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. , 2018, The Lancet. Infectious diseases.

[16]  Pardis C Sabeti,et al.  Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever , 2018, Scientific Reports.

[17]  B. R. Noack,et al.  New Lineage of Lassa Virus, Togo, 2016 , 2018, Emerging infectious diseases.

[18]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[19]  Donald S. Grant,et al.  Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever , 2017, Nature Medicine.

[20]  K. Chandran,et al.  Structural basis for antibody-mediated neutralization of Lassa virus , 2017, Science.

[21]  J. Koehler,et al.  Laboratory Diagnosis of Lassa Fever , 2017, Journal of Clinical Microbiology.

[22]  S. Plotkin.  Vaccines for epidemic infections and the role of CEPI , 2017, Human vaccines & immunotherapeutics.

[23]  O. Faye,et al.  Experiences of outbreak laboratory management in the Ebola Disease outbreak in West-Africa 2014-2015 (Forthcoming) , 2016 .

[24]  Donald S. Grant,et al.  Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. , 2016, Antiviral research.

[25]  Pardis C Sabeti,et al.  Unbiased Deep Sequencing of RNA Viruses from Clinical Samples , 2016, Journal of visualized experiments : JoVE.

[26]  Pardis C Sabeti,et al.  Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits , 2016, Nature Communications.

[27]  S. Günther,et al.  New Hosts of The Lassa Virus , 2016, Scientific Reports.

[28]  Virgil L. Woods,et al.  Crystal Structure of the Oligomeric Form of Lassa Virus Matrix Protein Z , 2016, Journal of Virology.

[29]  K. Lokuge,et al.  Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. , 2015, Journal of Clinical Investigation.

[30]  N. Forrester,et al.  Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage , 2015, Front. Microbiol..

[31]  Elizabeth M. Ryan,et al.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus , 2015, Cell.

[32]  S. Günther,et al.  International External Quality Assessment Study for Molecular Detection of Lassa Virus , 2015, PLoS neglected tropical diseases.

[33]  Dafna M. Abelson,et al.  Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak. , 2015, Viral immunology.

[34]  Pardis C Sabeti,et al.  Lassa Fever in Post-Conflict Sierra Leone , 2014, PLoS neglected tropical diseases.

[35]  Robert J. Fischer,et al.  Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali , 2013, PLoS neglected tropical diseases.

[36]  B. Grenfell,et al.  Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics , 2012, Proceedings of the National Academy of Sciences.

[37]  Donald S. Grant,et al.  Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection , 2011, Virology Journal.

[38]  Pardis C Sabeti,et al.  Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report , 2011, Virology Journal.

[39]  N. Friedman,et al.  Trinity: reconstructing a full-length transcriptome without a genome from RNA-Seq data , 2011, Nature Biotechnology.

[40]  James E. Robinson,et al.  Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report , 2011, Virology Journal.

[41]  N. Friedman,et al.  Trinity : reconstructing a full-length transcriptome without a genome from RNA-Seq data , 2016 .

[42]  S. Günther,et al.  Laboratory Diagnosis of Lassa Fever, Liberia , 2010, Emerging infectious diseases.

[43]  Augustine Goba,et al.  Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. , 2010, The American journal of tropical medicine and hygiene.

[44]  N. Van Rooijen,et al.  Vesicular Stomatitis Virus Genomic RNA Persists In Vivo in the Absence of Viral Replication , 2009, Journal of Virology.

[45]  R. Tesh,et al.  Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance , 2008, Virology Journal.

[46]  S. Günther,et al.  Mastomys natalensis and Lassa Fever, West Africa , 2006, Emerging infectious diseases.

[47]  C. Drosten,et al.  False-Negative Results of PCR Assay with Plasma of Patients with Severe Viral Hemorrhagic Fever , 2002, Journal of Clinical Microbiology.

[48]  J. McCormick,et al.  Lassa fever. , 2002, Current topics in microbiology and immunology.

[49]  T. Ksiazek,et al.  Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. , 2001, Vector borne and zoonotic diseases.

[50]  T. Ksiazek,et al.  Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation , 2000, Journal of Clinical Microbiology.

[51]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[52]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[53]  J. B. McCormick,et al.  A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. , 1988, BMJ.

[54]  J. McCormick,et al.  A case-control study of the clinical diagnosis and course of Lassa fever. , 1987, The Journal of infectious diseases.

[55]  P. Jahrling,et al.  Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay , 1984, Journal of clinical microbiology.

[56]  J. McCormick,et al.  Pathologic and virologic study of fatal Lassa fever in man. , 1982, The American journal of pathology.

[57]  J. V. Lange,et al.  Indirect immunofluorescence for the diagnosis of Lassa fever infection. , 1975, Bulletin of the World Health Organization.

[58]  T. Monath,et al.  Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. , 1974, The American journal of tropical medicine and hygiene.